Campbell named new CEO of NIH Foundation

The board of directors of the Foundation for the National Institutes of Health (FNIH) has appointed Scott Campbell, PhD, as its new executive director and CEO.

Prior to his appointment, Campbell served as the national vice president of research programs at the American Diabetes Association, and he continues to serve as a senior consultant to the China-America Institute of Diabetic Complications in the School of Pharmacy at Wenzhou Medical College in Zhejiang, China, stated the FNIH. 

Campbell will replace former executive director Amy Porter, who resigned in February, said the Bethesda, Md.-based foundation.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.